Only a takeover bid can mobilise the SP, else it's a dead stock, good company though, with good core values, I don't see no reason for a bid by one of the big players. BNYMC, 70% holders, should proactive look to sell off the company to a biotech giant, rather than pettyfully offload small chunks on retail buyers, resulting in SP staying laughably low. Shameful.
